Published in J Cardiovasc Transl Res on September 05, 2013
Study of ONO-2506 in Patients With Acute Ischemic Stroke | NCT00229177
Inflammation in chronic obstructive pulmonary disease and its role in cardiovascular disease and lung cancer. Clin Transl Med (2015) 0.95
Therapeutically targeting neuroinflammation and microglia after acute ischemic stroke. Biomed Res Int (2014) 0.87
Regulatory CD8(+)CD122 (+) T-cells predominate in CNS after treatment of experimental stroke in male mice with IL-10-secreting B-cells. Metab Brain Dis (2014) 0.84
Astragaloside IV for Experimental Focal Cerebral Ischemia: Preclinical Evidence and Possible Mechanisms. Oxid Med Cell Longev (2017) 0.83
Anti-Inflammatory Effects of Traditional Chinese Medicines against Ischemic Injury in In Vivo Models of Cerebral Ischemia. Evid Based Complement Alternat Med (2016) 0.80
Sex differences in stroke therapies. J Neurosci Res (2017) 0.79
Metabolic Syndrome Augments the Risk of Early Neurological Deterioration in Acute Ischemic Stroke Patients Independent of Inflammatory Mediators: A Hospital-Based Prospective Study. Oxid Med Cell Longev (2016) 0.78
Roles of Sestrin2 and Ribosomal Protein S6 in Transient Global Ischemia-Induced Hippocampal Neuronal Injury. Int J Mol Sci (2015) 0.77
Significance of decreased serum interleukin-10 levels in the progression of cerebral infarction. Clin Exp Med (2015) 0.76
Inhibition of cerebral ischemia/reperfusion injury-induced apoptosis: nicotiflorin and JAK2/STAT3 pathway. Neural Regen Res (2017) 0.75
Quantitative Identification of Compound-Dependent On-Modules and Differential Allosteric Modules From Homologous Ischemic Networks. CPT Pharmacometrics Syst Pharmacol (2016) 0.75
The Role of the Neuroprotective Factor Npas4 in Cerebral Ischemia. Int J Mol Sci (2015) 0.75
Serum Hepcidin Levels in Childhood-Onset Ischemic Stroke: A Case-Control Study. Medicine (Baltimore) (2016) 0.75
Neuroprotective Effect of Paeonol Mediates Anti-Inflammation via Suppressing Toll-Like Receptor 2 and Toll-Like Receptor 4 Signaling Pathways in Cerebral Ischemia-Reperfusion Injured Rats. Evid Based Complement Alternat Med (2016) 0.75
Microglia and Monocyte-Derived Macrophages in Stroke. Neurotherapeutics (2016) 0.75
Association between genetic polymorphisms of interleukins and cerebral infarction risk: a meta-analysis. Biosci Rep (2016) 0.75
Molecular and Cellular Responses to Interleukin-4 Treatment in a Rat Model of Transient Ischemia. J Neuropathol Exp Neurol (2016) 0.75
Danshen-Chuanxiong-Honghua Ameliorates Cerebral Impairment and Improves Spatial Cognitive Deficits after Transient Focal Ischemia and Identification of Active Compounds. Front Pharmacol (2017) 0.75
Role of TLR4 (C1196T) and CD14 (C-260T) Polymorphisms in Development of Ischemic Stroke, Its Subtypes and Hemorrhagic Stroke. J Mol Neurosci (2017) 0.75
TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity (2006) 29.29
Adhesion receptors of the immune system. Nature (1990) 28.86
Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science (1995) 17.76
Biologic basis for interleukin-1 in disease. Blood (1996) 16.04
Microglia: a sensor for pathological events in the CNS. Trends Neurosci (1996) 12.00
A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes. Nature (1992) 9.96
The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol (2006) 9.61
ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions. Microbiol Mol Biol Rev (2004) 9.54
The mitogen-activated protein kinase signal transduction pathway. J Biol Chem (1993) 8.77
Tripping the switch fantastic: how a protein kinase cascade can convert graded inputs into switch-like outputs. Trends Biochem Sci (1996) 7.54
Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol (2004) 6.78
The immunology of stroke: from mechanisms to translation. Nat Med (2011) 6.53
Leukocyte rolling and extravasation are severely compromised in P selectin-deficient mice. Cell (1993) 6.05
The pro- and anti-inflammatory properties of the cytokine interleukin-6. Biochim Biophys Acta (2011) 5.72
Signal transduction through MAP kinase cascades. Adv Cancer Res (1998) 5.65
Role of matrix metalloproteinases in delayed cortical responses after stroke. Nat Med (2006) 5.10
Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia. J Neurosci (2001) 4.99
Role of T lymphocytes and interferon-gamma in ischemic stroke. Circulation (2006) 4.61
Inflammatory mechanisms in ischemic stroke: role of inflammatory cells. J Leukoc Biol (2010) 4.37
Immune function of astrocytes. Glia (2001) 4.05
Selective ablation of proliferating microglial cells exacerbates ischemic injury in the brain. J Neurosci (2007) 3.93
Experimental stroke induces massive, rapid activation of the peripheral immune system. J Cereb Blood Flow Metab (2006) 3.91
Broad expression of Toll-like receptors in the human central nervous system. J Neuropathol Exp Neurol (2002) 3.53
Inflammatory mediators and stroke: new opportunities for novel therapeutics. J Cereb Blood Flow Metab (1999) 3.48
The role of interleukin-1 in disease. N Engl J Med (1993) 3.45
Tumor necrosis factor-alpha. A mediator of focal ischemic brain injury. Stroke (1997) 3.26
Plasma metalloproteinase-9 concentration predicts hemorrhagic transformation in acute ischemic stroke. Stroke (2003) 3.18
MAPK signalling pathways as molecular targets for anti-inflammatory therapy--from molecular mechanisms to therapeutic benefits. Biochim Biophys Acta (2005) 3.17
Generation of biologically active IL-1 beta by matrix metalloproteinases: a novel caspase-1-independent pathway of IL-1 beta processing. J Immunol (1998) 3.04
NF-kappaB is activated and promotes cell death in focal cerebral ischemia. Nat Med (1999) 2.96
Toll-like receptor 4 is involved in brain damage and inflammation after experimental stroke. Circulation (2007) 2.94
TLR signaling tailors innate immune responses in human microglia and astrocytes. J Immunol (2005) 2.94
Interleukin-1 as a pathogenetic mediator of ischemic brain damage in rats. Stroke (1995) 2.81
Acute ischaemic stroke and infection: recent and emerging concepts. Lancet Neurol (2008) 2.77
Inflammatory mechanisms after ischemia and stroke. J Neuropathol Exp Neurol (2003) 2.57
Monocyte chemoattractant protein-1 regulation of blood-brain barrier permeability. J Cereb Blood Flow Metab (2005) 2.45
Acute Stroke Therapy by Inhibition of Neutrophils (ASTIN): an adaptive dose-response study of UK-279,276 in acute ischemic stroke. Stroke (2003) 2.42
A randomised phase II study of interleukin-1 receptor antagonist in acute stroke patients. J Neurol Neurosurg Psychiatry (2005) 2.41
Stroke. Lancet (2003) 2.40
Tumor necrosis factor-alpha expression in ischemic neurons. Stroke (1994) 2.37
The many faces of tumor necrosis factor in stroke. Nat Med (2002) 2.33
TLR2 is constitutively expressed within the kidney and participates in ischemic renal injury through both MyD88-dependent and -independent pathways. J Immunol (2007) 2.32
Interleukin 1 in the brain: biology, pathology and therapeutic target. Trends Neurosci (2000) 2.27
TIPE2, a negative regulator of innate and adaptive immunity that maintains immune homeostasis. Cell (2008) 2.26
Inflammatory cytokines in experimental and human stroke. J Cereb Blood Flow Metab (2012) 2.25
Tumor necrosis factors alpha and beta protect neurons against amyloid beta-peptide toxicity: evidence for involvement of a kappa B-binding factor and attenuation of peroxide and Ca2+ accumulation. Proc Natl Acad Sci U S A (1995) 2.24
BDNF protects the neonatal brain from hypoxic-ischemic injury in vivo via the ERK pathway. J Neurosci (2000) 2.22
Systemic inflammation alters the kinetics of cerebrovascular tight junction disruption after experimental stroke in mice. J Neurosci (2008) 2.21
Role of IL-1alpha and IL-1beta in ischemic brain damage. J Neurosci (2001) 2.20
Cerebral protection in homozygous null ICAM-1 mice after middle cerebral artery occlusion. Role of neutrophil adhesion in the pathogenesis of stroke. J Clin Invest (1996) 2.19
Neutrophils roll on adherent neutrophils bound to cytokine-induced endothelial cells via L-selectin on the rolling cells. J Exp Med (1994) 2.16
MEK1 protein kinase inhibition protects against damage resulting from focal cerebral ischemia. Proc Natl Acad Sci U S A (1999) 2.16
CD4(+) T-lymphocytes mediate ischemia/reperfusion-induced inflammatory responses in mouse liver. J Clin Invest (1997) 2.15
Reduced cerebral ischemia-reperfusion injury in Toll-like receptor 4 deficient mice. Biochem Biophys Res Commun (2006) 2.10
Redistribution of alpha-granules and their contents in thrombin-stimulated platelets. J Cell Biol (1984) 2.06
Molecular basis of NF-κB signaling. Annu Rev Biophys (2013) 2.03
Mechanisms of immune suppression by interleukin-10 and transforming growth factor-beta: the role of T regulatory cells. Immunology (2006) 2.03
Systemic infection, inflammation and acute ischemic stroke. Neuroscience (2008) 2.03
Activation and involvement of p38 mitogen-activated protein kinase in glutamate-induced apoptosis in rat cerebellar granule cells. J Biol Chem (1997) 2.02
IL-6: an early marker for outcome in acute ischemic stroke. Acta Neurol Scand (2005) 2.01
Proteolytic cascade enzymes increase in focal cerebral ischemia in rat. J Cereb Blood Flow Metab (1996) 1.99
Microglia protect neurons against ischemia by synthesis of tumor necrosis factor. J Neurosci (2009) 1.97
Post-ischemic brain damage: pathophysiology and role of inflammatory mediators. FEBS J (2009) 1.95
Use of anti-ICAM-1 therapy in ischemic stroke: results of the Enlimomab Acute Stroke Trial. Neurology (2001) 1.93
Overexpression of monocyte chemoattractant protein 1 in the brain exacerbates ischemic brain injury and is associated with recruitment of inflammatory cells. J Cereb Blood Flow Metab (2003) 1.93
Chemokines and their receptors in the central nervous system. Front Neuroendocrinol (2001) 1.93
IL-10 reduces rat brain injury following focal stroke. Neurosci Lett (1998) 1.90
Interleukin-10 in the brain. Crit Rev Immunol (2001) 1.89
NF-kappaB signaling in cerebral ischemia. Neuroscience (2008) 1.88
Involvement of matrix metalloproteinase in neuroblast cell migration from the subventricular zone after stroke. J Neurosci (2006) 1.85
A vicious cycle involving release of heat shock protein 60 from injured cells and activation of toll-like receptor 4 mediates neurodegeneration in the CNS. J Neurosci (2008) 1.85
Activation of Toll-like receptor 4 signaling contributes to hippocampal neuronal death following global cerebral ischemia/reperfusion. J Neuroimmunol (2007) 1.84
TLR2 has a detrimental role in mouse transient focal cerebral ischemia. Biochem Biophys Res Commun (2007) 1.84
Activation of interleukin-1 beta by a co-induced protease. FEBS Lett (1989) 1.83
Leukocyte adhesion--structure and function of human leukocyte beta2-integrins and their cellular ligands. Eur J Biochem (1997) 1.81
High mobility group box 1 protein is released by neural cells upon different stresses and worsens ischemic neurodegeneration in vitro and in vivo. J Neurochem (2007) 1.77
The P-selectin glycoprotein ligand from human neutrophils displays sialylated, fucosylated, O-linked poly-N-acetyllactosamine. J Biol Chem (1994) 1.74
Toll-like receptor signaling in endogenous neuroprotection and stroke. Neuroscience (2008) 1.73
Toll-like receptor 3 on adult human astrocytes triggers production of neuroprotective mediators. Glia (2006) 1.72
Proliferating resident microglia after focal cerebral ischaemia in mice. J Cereb Blood Flow Metab (2007) 1.71
Regulation of apoptosis by insulin-like growth factor (IGF)-I. Cytokine Growth Factor Rev (2006) 1.71
Matrix metalloproteinase expression after human cardioembolic stroke: temporal profile and relation to neurological impairment. Stroke (2001) 1.69
How does peripheral lipopolysaccharide induce gene expression in the brain of rats? Toxicology (2004) 1.65
Neuronal protection in stroke by an sLex-glycosylated complement inhibitory protein. Science (1999) 1.65
The harms and benefits of inflammatory and immune responses in vascular disease. Stroke (2006) 1.63
Cerebral interleukin-6 is neuroprotective during permanent focal cerebral ischemia in the rat. J Cereb Blood Flow Metab (1998) 1.63
Mice deficient in fractalkine are less susceptible to cerebral ischemia-reperfusion injury. J Neuroimmunol (2002) 1.62
Peroxisome proliferator-activated receptor-gamma agonists induce neuroprotection following transient focal ischemia in normotensive, normoglycemic as well as hypertensive and type-2 diabetic rodents. J Neurochem (2007) 1.61
MCP-1, MIP-1, IL-8 and ischemic cerebral tissue enhance human bone marrow stromal cell migration in interface culture. Hematology (2002) 1.59
Inflammation in ischemic brain injury: timing is important. Crit Rev Neurobiol (2006) 1.57
Astrocytes: targets for neuroprotection in stroke. Cent Nerv Syst Agents Med Chem (2011) 1.56
Intrathecal release of pro- and anti-inflammatory cytokines during stroke. Clin Exp Immunol (1997) 1.51
ERK5: structure, regulation and function. Cell Signal (2012) 1.50
Migration of enhanced green fluorescent protein expressing bone marrow-derived microglia/macrophage into the mouse brain following permanent focal ischemia. Neuroscience (2003) 1.50
Increased gelatinase A (MMP-2) and gelatinase B (MMP-9) activities in human brain after focal ischemia. Neurosci Lett (1997) 1.49
The role of interleukin 1 in acute neurodegeneration and stroke: pathophysiological and therapeutic implications. J Clin Invest (1997) 1.48
Tumor necrosis factor is a brain damaging cytokine in cerebral ischemia. Shock (1997) 1.48
Post-ischemic inflammation: molecular mechanisms and therapeutic implications. Neurol Res (2004) 1.48
Interleukin-10 modulates neuronal threshold of vulnerability to ischaemic damage. Eur J Neurosci (2000) 1.47
Sequencing of 50 human exomes reveals adaptation to high altitude. Science (2010) 11.27
Histone H2B monoubiquitination functions cooperatively with FACT to regulate elongation by RNA polymerase II. Cell (2006) 5.14
Ezh1 and Ezh2 maintain repressive chromatin through different mechanisms. Mol Cell (2008) 4.44
Inflammatory mechanisms in ischemic stroke: role of inflammatory cells. J Leukoc Biol (2010) 4.37
L3MBTL1, a histone-methylation-dependent chromatin lock. Cell (2007) 3.70
Frequent mutations of genes encoding ubiquitin-mediated proteolysis pathway components in clear cell renal cell carcinoma. Nat Genet (2011) 3.66
Functional stoichiometry of the unitary calcium-release-activated calcium channel. Proc Natl Acad Sci U S A (2008) 3.07
Limitations of methods for measuring out-of-pocket and catastrophic private health expenditures. Bull World Health Organ (2009) 2.89
Cryo-EM study of the chromatin fiber reveals a double helix twisted by tetranucleosomal units. Science (2014) 2.37
Telomere elongation in induced pluripotent stem cells from dyskeratosis congenita patients. Nature (2010) 2.36
MicroRNAs inhibit the translation of target mRNAs on the endoplasmic reticulum in Arabidopsis. Cell (2013) 2.28
Determinants of CD4+ T cell recovery during suppressive antiretroviral therapy: association of immune activation, T cell maturation markers, and cellular HIV-1 DNA. J Infect Dis (2006) 2.26
Spontaneous control of primary hepatitis C virus infection and immunity against persistent reinfection. Gastroenterology (2009) 2.24
Fatal consequences of a simple mistake: how can a patient be saved from inadvertent intrathecal vincristine? Clin Neurol Neurosurg (2010) 2.15
Genotyping pooled DNA on microarrays: a systematic genome screen of thousands of SNPs in large samples to detect QTLs for complex traits. Behav Genet (2004) 2.14
Evaluation of interspinous process distraction device (X-STOP) in a representative patient cohort. World Neurosurg (2012) 2.14
Dynamics of total, linear nonintegrated, and integrated HIV-1 DNA in vivo and in vitro. J Infect Dis (2008) 2.08
Adrenocorticotropic hormone-producing pituitary carcinoma with intracranial metastases. World Neurosurg (2011) 2.08
Crop diversity for yield increase. PLoS One (2009) 2.02
Impact of body habitus on fluoroscopic radiation emission during minimally invasive spine surgery. J Neurosurg Spine (2014) 2.00
Signaling pathways for early brain injury after subarachnoid hemorrhage. J Cereb Blood Flow Metab (2004) 1.99
Mmp-9 deficiency enhances collagenase-induced intracerebral hemorrhage and brain injury in mutant mice. J Cereb Blood Flow Metab (2004) 1.97
Molecular insights and therapeutic targets for blood-brain barrier disruption in ischemic stroke: critical role of matrix metalloproteinases and tissue-type plasminogen activator. Neurobiol Dis (2010) 1.90
Structure of a CENP-A-histone H4 heterodimer in complex with chaperone HJURP. Genes Dev (2011) 1.87
Spinal epidural abscess: a diagnostic challenge. Am Fam Physician (2002) 1.84
MicroRNA: past and present. Front Biosci (2007) 1.79
Genomic and proteomic analyses of the fungus Arthrobotrys oligospora provide insights into nematode-trap formation. PLoS Pathog (2011) 1.72
The program for processing newly synthesized histones H3.1 and H4. Nat Struct Mol Biol (2010) 1.71
Complications of posterior cranial fossa surgery--an institutional experience of 500 patients. Surg Neurol (2009) 1.71
MicroRNA-127 modulates fetal lung development. Physiol Genomics (2009) 1.68
Genotyping DNA pools on microarrays: tackling the QTL problem of large samples and large numbers of SNPs. BMC Genomics (2005) 1.68
MicroRNA-224 is involved in transforming growth factor-beta-mediated mouse granulosa cell proliferation and granulosa cell function by targeting Smad4. Mol Endocrinol (2010) 1.61
Application of nonlinear dynamics analysis in assessing unconsciousness: a preliminary study. Clin Neurophysiol (2010) 1.59
An expedited code stroke protocol is feasible and safe. Stroke (2006) 1.57
3D in vivo optical coherence tomography based on a low-voltage, large-scan-range 2D MEMS mirror. Opt Express (2010) 1.55
NIHSS training and certification using a new digital video disk is reliable. Stroke (2005) 1.53
Isolation of highly pure alveolar epithelial type I and type II cells from rat lungs. Lab Invest (2004) 1.51
microRNA-365, down-regulated in colon cancer, inhibits cell cycle progression and promotes apoptosis of colon cancer cells by probably targeting Cyclin D1 and Bcl-2. Carcinogenesis (2011) 1.48
Zinc-finger-nucleases mediate specific and efficient excision of HIV-1 proviral DNA from infected and latently infected human T cells. Nucleic Acids Res (2013) 1.48
Graded activation of CRAC channel by binding of different numbers of STIM1 to Orai1 subunits. Cell Res (2010) 1.48
Germline stem cells and neo-oogenesis in the adult human ovary. Dev Biol (2007) 1.48
Implanted ventricular shunts in the United States: the billion-dollar-a-year cost of hydrocephalus treatment. Neurosurgery (2005) 1.47
National Institutes of Health Stroke Scale certification is reliable across multiple venues. Stroke (2009) 1.45
Serum bisphenol-A concentration and sex hormone levels in men. Fertil Steril (2013) 1.45
Influence of cocaine on ruptured intracranial aneurysms: a case control study of poor prognostic indicators. J Neurosurg (2008) 1.45
Low-level amplification of oncogenes correlates inversely with age for patients with nontypical meningiomas. World Neurosurg (2011) 1.45
Paraclinoid carotid aneurysms. J Clin Neurosci (2010) 1.44
The utility of bone cement to prevent lead migration with minimally invasive placement of spinal cord stimulator laminectomy leads. Neurosurgery (2012) 1.43
Intracranial fungal granuloma: analysis of 40 patients and review of the literature. Surg Neurol (2005) 1.42
Retracted A meta-analysis of external fixator versus intramedullary nails for open tibial fracture fixation. J Orthop Surg Res (2014) 1.42
Plasma catecholamine release-inhibitory peptide catestatin in patients with essential hypertension. J Cardiovasc Med (Hagerstown) (2011) 1.41
Susruta and ancient Indian neurosurgery. World Neurosurg (2011) 1.41
The pterional and suprabrow approaches for aneurysm surgery: a systematic review of intraoperative rupture rates in 9488 aneurysms. World Neurosurg (2013) 1.41
The consumption of low-mineral bottled water increases the risk of cardiovascular disease: an experimental study of rabbits and young men. Int J Cardiol (2013) 1.41
A randomized, controlled trial of acceptance and commitment therapy and cognitive-behavioral therapy for chronic pain. Pain (2011) 1.41
Regulation of transcription through acetylation of H3K122 on the lateral surface of the histone octamer. Cell (2013) 1.40
The role of flexion and extension computed tomography with reconstruction in clearing the cervical spine in trauma patients: a pilot study. J Neurosurg Spine (2011) 1.40
The use of bioabsorbable screws to fix Type II odontoid fractures: a biomechanical study. J Neurosurg Spine (2011) 1.40
Reoperations after surgery for lumbar spinal stenosis. World Neurosurg (2011) 1.40
A technique to identify core journals for neurosurgery using citation scatter analysis and the Bradford distribution across neurosurgery journals. J Neurosurg (2013) 1.39
Transient oculomotor nerve palsy after topical administration of intracisternal papaverine. Acta Neurochir (Wien) (2010) 1.39
Zscan4 promotes genomic stability during reprogramming and dramatically improves the quality of iPS cells as demonstrated by tetraploid complementation. Cell Res (2012) 1.39
T-bet and eomesodermin are required for T cell-mediated antitumor immune responses. J Immunol (2010) 1.36
Single-layer behavior and its breakdown in twisted graphene layers. Phys Rev Lett (2011) 1.34
Predictive factors for dural tear and cerebrospinal fluid leakage in patients undergoing lumbar surgery. J Neurosurg Spine (2006) 1.33
Gene silencing in alveolar type II cells using cell-specific promoter in vitro and in vivo. Nucleic Acids Res (2004) 1.33
Periostin mediates vascular smooth muscle cell migration through the integrins alphavbeta3 and alphavbeta5 and focal adhesion kinase (FAK) pathway. Atherosclerosis (2009) 1.33
Polyomavirus middle T-induced mammary intraepithelial neoplasia outgrowths: single origin, divergent evolution, and multiple outcomes. Mol Cancer Ther (2004) 1.33
L3MBTL2 protein acts in concert with PcG protein-mediated monoubiquitination of H2A to establish a repressive chromatin structure. Mol Cell (2011) 1.32
IL-33 synergizes with TCR and IL-12 signaling to promote the effector function of CD8+ T cells. Eur J Immunol (2011) 1.32
miR-148b functions as a tumor suppressor in pancreatic cancer by targeting AMPKα1. Mol Cancer Ther (2012) 1.29
ASAP1, a gene at 8q24, is associated with prostate cancer metastasis. Cancer Res (2008) 1.29
Identifying functional miRNA-mRNA regulatory modules with correspondence latent dirichlet allocation. Bioinformatics (2010) 1.28
SDF-1/CXCR4 axis modulates bone marrow mesenchymal stem cell apoptosis, migration and cytokine secretion. Protein Cell (2011) 1.27
Identification of rat lung-specific microRNAs by micoRNA microarray: valuable discoveries for the facilitation of lung research. BMC Genomics (2007) 1.27
Improved orange and red Ca²± indicators and photophysical considerations for optogenetic applications. ACS Chem Neurosci (2013) 1.26
CD40/CD40 ligand signaling in mouse cerebral microvasculature after focal ischemia/reperfusion. Circulation (2005) 1.25
Histone tails regulate DNA methylation by allosterically activating de novo methyltransferase. Cell Res (2011) 1.24
Identification of two novel markers for alveolar epithelial type I and II cells. Biochem Biophys Res Commun (2004) 1.24
Inhibition of apoptosis by hyperbaric oxygen in a rat focal cerebral ischemic model. J Cereb Blood Flow Metab (2003) 1.23
Effect of cholesterol depletion on exocytosis of alveolar type II cells. Am J Respir Cell Mol Biol (2006) 1.23
Association of telomere length with authentic pluripotency of ES/iPS cells. Cell Res (2011) 1.22
Coevolutionary patterns in plasminogen activation. Proc Natl Acad Sci U S A (2003) 1.22
Combinatorial readout of unmodified H3R2 and acetylated H3K14 by the tandem PHD finger of MOZ reveals a regulatory mechanism for HOXA9 transcription. Genes Dev (2012) 1.21
T-cell-mediated tumor immune surveillance and expression of B7 co-inhibitory molecules in cancers of the upper gastrointestinal tract. Immunol Res (2011) 1.21
A novel approach for the construction of multiple shRNA expression vectors. J Gene Med (2007) 1.21
Primer extension-based method for the generation of a siRNA/miRNA expression vector. Physiol Genomics (2007) 1.21
Role of specific microRNAs for endothelial function and angiogenesis. Biochem Biophys Res Commun (2009) 1.21
Telomere length predicts embryo fragmentation after in vitro fertilization in women--toward a telomere theory of reproductive aging in women. Am J Obstet Gynecol (2005) 1.20
Factor V Leiden and risk of ischemic stroke in nonvalvular atrial fibrillation: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. J Thromb Thrombolysis (2003) 1.20
Piglets cloned from induced pluripotent stem cells. Cell Res (2012) 1.19
Caspase inhibitors prevent endothelial apoptosis and cerebral vasospasm in dog model of experimental subarachnoid hemorrhage. J Cereb Blood Flow Metab (2004) 1.19
Structure of the variant histone H3.3-H4 heterodimer in complex with its chaperone DAXX. Nat Struct Mol Biol (2012) 1.18
Molecular insights into the heterogeneity of telomere reprogramming in induced pluripotent stem cells. Cell Res (2011) 1.18
Trans-differentiation of alveolar epithelial type II cells to type I cells involves autocrine signaling by transforming growth factor beta 1 through the Smad pathway. J Biol Chem (2006) 1.17
Identification of a novel HtrA1-susceptible cleavage site in human aggrecan: evidence for the involvement of HtrA1 in aggrecan proteolysis in vivo. J Biol Chem (2009) 1.17
The Methods Behind PH WINS. J Public Health Manag Pract (2015) 1.17
Magnetic nanoparticle of Fe3O4 and 5-bromotetrandrin interact synergistically to induce apoptosis by daunorubicin in leukemia cells. Int J Nanomedicine (2009) 1.17